Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Informed Consent in IBD Trials: Where We Are and Where We Need to Go.

Kurin M, Katz J, Kodish E, Lashner B.

Inflamm Bowel Dis. 2019 Jun 18;25(7):1115-1119. doi: 10.1093/ibd/izz067.

PMID:
30989217
2.

Prevalence of Nausea and Vomiting in Adults Using Ropinirole: A Systematic Review and Meta-Analysis.

Kurin M, Bielefeldt K, Levinthal DJ.

Dig Dis Sci. 2018 Mar;63(3):687-693. doi: 10.1007/s10620-018-4937-3. Epub 2018 Jan 30. Review.

PMID:
29383607
3.

Clinical peritonitis from allergy to silicone ventriculoperitoneal shunt.

Kurin M, Lee K, Gardner P, Fajt M, Umapathy C, Fasanella K.

Clin J Gastroenterol. 2017 Jun;10(3):229-231. doi: 10.1007/s12328-017-0729-0. Epub 2017 Mar 6.

PMID:
28265895
4.

Clinical Outcomes and Cost-effectiveness of Primary Prophylaxis of Febrile Neutropenia During Adjuvant Docetaxel and Cyclophosphamide Chemotherapy for Breast Cancer.

Yu JL, Chan K, Kurin M, Pasetka M, Kiss A, Sridhar SS, Warner E.

Breast J. 2015 Nov-Dec;21(6):658-64. doi: 10.1111/tbj.12501. Epub 2015 Sep 20.

PMID:
26387577
5.

Yellow nail syndrome: a case report and review of treatment options.

Kurin M, Wiesen J, Mehta AC.

Clin Respir J. 2017 Jul;11(4):405-410. doi: 10.1111/crj.12354. Epub 2015 Sep 24. Review.

PMID:
26257383
6.

Fas-mediated killing of primary prostate cancer cells is increased by mitoxantrone and docetaxel.

Symes JC, Kurin M, Fleshner NE, Medin JA.

Mol Cancer Ther. 2008 Sep;7(9):3018-28. doi: 10.1158/1535-7163.MCT-08-0335.

Supplemental Content

Support Center